Search Results - "Custodio, Ana. B."

SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019) by Martín-Richard, M., Carmona-Bayonas, A., Custodio, Ana. B., Gallego, J., Jiménez-Fonseca, P., Reina, J. J., Richart, P., Rivera, F., Alsina, M., Sastre, J.

“…Gastric cancer (GC) is the fifth most common cancer worldwide with a varied geographic distribution and an aggressive behavior. In Spain, it represents the…”
Get full text

Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer by Feliu, Jaime, Salud, Antonieta, Safont, Maria J, García-Girón, Carlos, Aparicio, Jorge, Losa, Ferran, Bosch, Carlos, Escudero, Pilar, Casado, Enrique, Jorge, Monica, Bohn, Uriel, Pérez-Carrión, Ramon, Carmona, Alberto, Custodio, Ana B, Maurel, Joan

“…Studies suggest a relationship between hypertension and outcome in bevacizumab-treated patients with metastatic colorectal cancer (mCRC). We performed a…”
Get full text

3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients by Vargas, Teodoro, Moreno-Rubio, Juan, Herranz, Jesús, Cejas, Paloma, Molina, Susana, Mendiola, Marta, Burgos, Emilio, Custodio, Ana B, De Miguel, María, Martín-Hernández, Roberto, Reglero, Guillermo, Feliu, Jaime, Ramírez de Molina, Ana

“…Strong evidence suggests that lipid metabolism (LM) has an essential role in tumor growth to support special energetic and structural requirements of tumor…”
Get full text

ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients by Vargas, Teodoro, Moreno-Rubio, Juan, Herranz, Jesús, Cejas, Paloma, Molina, Susana, González-Vallinas, Margarita, Mendiola, Marta, Burgos, Emilio, Aguayo, Cristina, Custodio, Ana B, Machado, Isidro, Ramos, David, Gironella, Meritxell, Espinosa-Salinas, Isabel, Ramos, Ricardo, Martín-Hernández, Roberto, Risueño, Alberto, De Las Rivas, Javier, Reglero, Guillermo, Yaya, Ricardo, Fernández-Martos, Carlos, Aparicio, Jorge, Maurel, Joan, Feliu, Jaime, Ramírez de Molina, Ana

“…Lipid metabolism plays an essential role in carcinogenesis due to the requirements of tumoral cells to sustain increased structural, energetic and biosynthetic…”
Get full text

Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer by Vargas, Teodoro, Moreno-Rubio, Juan, Herranz, Jesús, Cejas, Paloma, Molina, Susana, González-Vallinas, Margarita, Ramos, Ricardo, Burgos, Emilio, Aguayo, Cristina, Custodio, Ana B., Reglero, Guillermo, Feliu, Jaime, Ramírez de Molina, Ana

“…Studies have recently suggested that metabolic syndrome and its components increase the risk of colorectal cancer. Both diseases are increasing in most…”
Get full text

The NETFIT trial: Smart wearable medical devices to assess the quality of life of patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET) by Molina Cerrillomd, Javier, Alonso-Gordoa, Teresa, Grande, Enrique, Benavent, Marta, del Olmo, Maria-Isabel, Custodio, Ana B., Hernando, Jorge, Garcia-Carbonero, Rocio, Teule, Alex, Alonso, Vicente, Pascual-Corrales, Eider, Araujo-Castro, Marta, Martinez Lago, Nieves, Capdevila, Jaume

“…e13627 Background: Patients diagnosed with an advanced NET are frequently deteriorating their quality of life due to tumor volume, hormone-release related…”
Get full text

Clinicopathological characteristics and outcomes of patients with deficient mismatch repair colorectal cancer by Viñal, David, Martinez-Perez, Daniel, Martínez-Recio, Sergio, Ruiz, Iciar, Jiménez Bou, Diego, Peña, Jesus, Martin-Montalvo, Gema, Rueda-Lara, Antonio, Alameda, Maria, Gutiérrez Sainz, Laura, Custodio, Ana B., Palacios, Maria Elena, Ghanem, Ismael, Rodriguez Salas, Nuria, Feliu, Jaime

“…Abstract only 181 Background: Patients with microsatellite-instability–high (MSI-H) or deficient mismatch repair (dMMR) colorectal cancer (CRC) represent a…”
Get full text

Predicting recurrence in patients with stage II and III colon cancer: Validation cohort and long-term follow-up of the experimental cohort by Viñal, David, Martinez-Perez, Daniel, Martínez-Recio, Sergio, Gutiérrez-Sainz, Laura, Ruiz-Gutierrez, Iciar, Jiménez-Bou, Diego, Peña-Lopez, Jesus, Alameda-Guijarro, Maria, Martin-Montalvo, Gema, Rueda-Lara, Antonio, Garcia-Leal, Andrea, Zwisler, Patricia, Palacios, Maria Elena, Custodio, Ana B., Feliu, Jaime, Rodriguez Salas, Nuria, Ghanem, Ismael

“…215 Background: The prognosis of stage II and III colon cancer is heterogeneous and current staging system do not accurately predict recurrence. We previously…”
Get full text

Prognostic value of tumor budding in patients with stage II and III colon cancer: A single-institution experience by Viñal, David, Rueda-Lara, Antonio, Martinez-Perez, Daniel, Zwisler, Patricia, Garcia-Leal, Andrea, Ruiz-Gutierrez, Iciar, Jiménez-Bou, Diego, Peña-Lopez, Jesus, Alameda-Guijarro, Maria, Martin-Montalvo, Gema, Perez-Wert, Pablo, Martínez-Recio, Sergio, Palacios, Maria Elena, Ghanem, Ismael, Custodio, Ana B., Gutiérrez-Sainz, Laura, Feliu, Jaime, Rodriguez Salas, Nuria

“…247 Background: Tumor budding has recently been recognized as one important prognostic factor for recurrence in patients with localized colon cancer…”
Get full text

Plasma biomarker study of lenvatinib in gastroenteropancreatic neuroendocrine tumors reveals Ang2 and FGF2 as predictors of treatment response: Results from the international phase II TALENT trial (GETNE 1509) by Capdevila, Jaume, Jimenez-Valerio, Gabriela, Martinez, Alba, Hernando, Jorge, Ibrahim, Toni, Fazio, Nicola, Lopez, Carlos, Teule, Alex, Valle, Juan W., Tafuto, Salvatore, Custodio, Ana B., Reed, Nicholas Simon, Raderer, Markus, Grande, Enrique, Garcia-Carbonero, Rocio, Jiménez-Fonseca, Paula, Alonso, Vicente, Casanovas, Oriol

“…Abstract only 4113 Background: Predictive biomarkers of response to antiangiogenics currently remain elusive, with several molecules discovered but not fully…”
Get full text

Development and validation of an early death risk score for older patients treated with chemotherapy for cancer by Feliu Batlle, Jaime, Pinto, Alvaro, Basterretxea, Laura, Paredero Pérez, Irene, Llabres, Elisenda, Jimenez-Munarriz, Beatriz, Rebollo, Maite Antonio, Losada Vila, Beatriz, Espinosa, Enrique, Girones, Regina, Custodio, Ana B., Muñoz, María del Mar, Díaz-Almirón, Mariana, Gómez-Mediavilla, Jeniffer, Torregrosa, Maria Dolores, Soler, Gemma, Cruz, Patricia, Higuera, Oliver, Molina-Garrido, MJ

“…Abstract only 12030 Background: Determining life expectancy in older patients is needed to select the best treatment strategy. We aimed to develop and validate…”
Get full text

Final results of the TALENT trial (GETNE1509): a prospective multicohort phase II study of lenvatinib in patients (pts) with G1/G2 advanced pancreatic (panNETs) and gastrointestinal (giNETs) neuroendocrine tumors (NETs) by Capdevila, Jaume, Fazio, Nicola, Lopez Lopez, Carlos, Teule, Alex, Valle, Juan W., Tafuto, Salvatore, Custodio, Ana B., Reed, Nicholas, Raderer, Markus, Grande, Enrique, Garcia-Carbonero, Rocio, Jiménez-Fonseca, Paula, Alonso, Vicente, Antonuzzo, Lorenzo, Spallanzani, Andrea, Berruti, Alfredo, Sevilla, Isabel, La Casta Munoa, Adelaida, Hernando-Cubero, Jorge, Ibrahim, Toni

“…Abstract only 4106 Background: Approved systemic therapies for advanced NETs have showed limited tumor shrinkage and no data of activity after progression to…”
Get full text

Predictive factors of grade 3-5 toxicity in older patients with cancer treated with chemotherapy: A prospective multicenter study by Feliu Batlle, Jaime, Basterretxea, Laura, Torregrosa, Maria Dolores, Llabres, Elisenda, Losada Vila, Beatriz, Jimenez-Munarriz, Beatriz, Rebollo, Maite Antonio, Custodio, Ana B., Girones, Regina, Cruz, Patricia, Sanchez, Mar Munoz, Pinto, Alvaro, Soler, Gemma, Soria Comes, Teresa, Telleria, Hellis, Molina-Garrido, MJ

“…Abstract only 11509 Background: Older patients have increased risk of toxicity from chemotherapy. The purpose of this study was to analyse predictive factors…”
Get full text

Progression-free survival (PFS) and subgroups analyses of lenvatinib in patients (pts) with G1/G2 advanced pancreatic (panNETs) and gastrointestinal (giNETs) neuroendocrine tumors (NETs): Updated results from the phase II TALENT trial (GETNE 1509) by Capdevila, Jaume, Fazio, Nicola, López-López, Carlos, Teule, Alexandre, Valle, Juan W., Tafuto, Salvatore, Custodio, Ana B., Reed, Nicholas, Raderer, Markus, Grande, Enrique, Garcia-Carbonero, Rocio, Jiménez-Fonseca, Paula, Alonso, Vicente, Antonuzzo, Lorenzo, Spallanzani, Andrea, Berruti, Alfredo, Sevilla, Isabel, La Casta Munoa, Adelaida, Hernando, Jorge, Ibrahim, Toni

“…Abstract only 332 Background: Pts with advanced G1/G2 NETs have limited treatment options with overall response rates (ORR) with targeted agents (TA) < 10%…”
Get full text

“First chemotherapy” or “first local” approach for liver-only synchronic metastasis rectal cancer? A single institution experience by Ghanem, Ismael, Higuera Gomez, Oliver, Mata, Alberto, Reyes, Jose, Rodriguez, Nuria, Castell, Jose, Custodio, Ana B., Martinez, Virginia, Pastrian, Laura Guerra, Feliu, Jaime

“…Abstract only 780 Background: Approximately 10% of patients (p) with rectal cancer have synchronic liver-only metastasis (RCSLM). Although local and systemic…”
Get full text

A phase II trial to assess the activity and safety of the hypoxia-activated prodrug evofosfamide (TH-302) in combination with sunitinib in patients with disseminated grade 1 and 2 pancreatic neuroendocrine tumors (pNET) as a first-line approach: The GETNE-1408 trial by Grande, Enrique, Castellano, Daniel E., Custodio, Ana B., Garcia-Carbonero, Rocio, González, Encarnación, López-López, Carlos, Munarriz, Javier, Sevilla, Isabel, Teule, Alexandre, Benavent Viñuales, Marta, Alonso, Teresa, Gajate Borau, Pablo, Palacios, José, Capdevila, Jaume

“…Abstract only TPS479 Background: Pancreatic-NETs are highly vascular tumors. The anti-angiogenetic sunitinib was approved in advanced pNETs based on…”
Get full text

Phase II studies of BEZ235 in patients with advanced pancreatic neuroendocrine tumors (pNET) by Salazar, Ramon, Verslype, Chris, Baudin, Eric, Libutti, Steven K., Yao, James C., Buzzoni, Roberto, Antonuzzo, Lorenzo, Hubner, Richard, García-Carbonero, Rocio, Custodio, Ana B., Wolin, Edward M., Turri, Sabine, Dey, Debarshi, Aimone, Paola, Sulovski, Joseph, Mukherjee, Nabanita, Herbst, Fabian, Fazio, Nicola

“…Abstract only…”
Get full text

Prognostic factors for survival in patients with advanced gastric cancer treated with chemotherapy by Mangas, Montserrat, Carmona Bayonas, Alberto, Sanchez Lorenzo, Maria Luisa, Ramchandani, Avinash, Garcia, Teresa, Custodio, Ana B., Lorenzo Barreto, Jose Enrique, Echavarria Diaz Guardamino, Isabel, Diaz Serrano, Asuncion, Cano, Juana Maria, Azkarate, Aitor, Longo, Federico, Mugica, Maitane, Sanchez, Rodrigo, Serrano, Raquel, Alvarez Manceñido, Felipe Jose, Alsina, Maria, Jiménez-Fonseca, Paula, Garrido, Marcelo, Gallego Plazas, Javier

“…Abstract only 142 Background: A prognostic model in advanced gastric cancer that integrates the Her2 status,histopathological classifications and other…”
Get full text

Temozolamide plus capecitabine as salvage treatment for patients with advanced neuroendocrine tumors (NETs) in the community setting by López-López, Carlos, Jiménez, Paula, Crespo, Guillermo, Grande, Enrique, Custodio, Ana B., Mangas-Izquierdo, M., Pérez Arnillas, Quionia, Barrio-Alonso, M. J., Soria Rivas, Ainara, Barriuso, Jorge

“…Abstract only e15169 Background: Streptozotocin and doxorubicin-based chemotherapy schemes have been widely used in the treatment of advanced NETs…”
Get full text

Predictive factors of grade 3-5 toxicity in elderly cancer patients treated with chemotherapy: A prospective multicenter study (TEP study: Toxicity in Elderly Patient) by Jimenez-Munarriz, Beatriz, Madero, Rosario, Jimenez Gordo, Ana M., Molina-Garrido, MJ, Saldana, Juana, Girones, Regina, Espinosa, Enrique, De Castro, Javier, Zamora, Pilar, Sanchez, Mar Munoz, Rebollo, Maite Antonio, Higuera, Oliver, Rodriguez, Nuria, Redondo, Andrés, Pinto, Alvaro, Custodio, Ana B., Bernal, Elsa, Feliu, Jaime

“…Abstract only…”
Get full text